Dr-Mark-Heffernan

Dr. Mark Heffernan is a Nexvet co-founder, and has served as Chief Executive Officer and a member of the Nexvet board of directors since April 2011. In 2003, Dr. Heffernan co-founded Opsona Therapeutics Ltd., an Irish biotechnology company focused on human mAbs for inflammatory and oncology diseases. He also worked in R&D and business development roles for two Australia biotechnology companies, Antisense Therapeutics Limited and Metabolic Pharmaceuticals Pty Ltd., for a number of years. Dr. Heffernan has a BSc in Biochemistry and Pharmacology and a Ph.D. in Biochemistry from Monash University (Australia).

Dr. Mark Heffernan is a Nexvet co-founder, and has served as Chief Executive Officer and a member of the Nexvet board of directors since April 2011. In 2003, Dr. Heffernan co-founded Opsona Therapeutics Ltd., an Irish biotechnology company focused on human mAbs for inflammatory and oncology diseases. He also worked in R&D and business development roles for two Australia biotechnology companies, Antisense Therapeutics Limited and Metabolic Pharmaceuticals Pty Ltd., for a number of years. Dr. Heffernan has a BSc in Biochemistry and Pharmacology and a Ph.D. in Biochemistry from Monash University (Australia).

No Comments

Post A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.